LungBlog

In lung cancer, a patient’s survival is poor with a wide variation in survival within the stage of disease. The aim of this study was to investigate the familial concordance in lung cancer survival by means of analyses of pairs with different degrees of familial relationships.

A substance called ellagic acid appears to help prevent lung cancer – at least in the lab, and both strawberries and raspberries are rich in ellagic acid.

University Hospitals Case Medical Center is currently enrolling patients in a clinical study for a new lung cancer vaccine.

Patients who have Phase III inoperable non-small cell lung cancer may qualify to take part in the study.

Workers who have been exposed to asbestos on the job are more likely to die from lung cancers, mesothelioma, and asbestosis, as well as from stomach cancer and stroke, according to one of the longest-running studies of British asbestos workers, published in Occupational and Environmental Medicine.

Researchers plan to present new data this weekend confirming what many doctors have long suspected: Iressa, a lung-cancer drug once thought to be a flop, could actually be of use to tens of thousands of patients — specifically, to Asians, nonsmokers and others with a certain genetic quirk.

Patients with locally advanced lung cancer who received a course of radiation therapy to their brain at the completion of their lung cancer treatment were less likely to develop brain metastases within the first year after treatment according to new research from the Radiation Therapy Oncology Group (RTOG).

The Translational Genomics Research Institute has hired a scientist to oversee its newest lab that aims to help discover ways to diagnose and treat disease.

The new lab will open this summer and will begin analyzing protein samples with the goal of developing new tests and treatments for diseases such as lung cancer.

Thousands of cancer doctors – and a good number of investors – will converge in Orlando this weekend to discuss the latest developments in cancer treatment.

Those notable studies will highlight advances in earlier treatments for lung cancer.

Ready for a little good news? Fewer people are dying from cancer these days, and the incidence of the disease is also on the wane, according to the American Cancer Society.

The decline in the lung cancer death rate among men is due to a decrease in tobacco use, says the American Cancer Society. The lung cancer death rate among women has stabilized after increasing for many decades, according to the Society.